Growth hormone deficiency MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
==MRI==
==MRI==
*[[Brain]] MRI may be helpful in the diagnosis of growth hormone deficiency. Findings on MRI include:
*[[Brain]] MRI may be helpful in the diagnosis of growth hormone deficiency. Findings on MRI include:
*[[Magnetic resonance imaging|MRI]] is highly sensitive to visualize the [[Hypothalamo-hypophyseal portal system|hypothalamo-hypophyseal tract]]. After the clinical and [[biochemical]] diagnosis of GHD is made.<ref name="pmid11095419">{{cite journal| author=Growth Hormone Research Society| title=Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. | journal=J Clin Endocrinol Metab | year= 2000 | volume= 85 | issue= 11 | pages= 3990-3 | pmid=11095419 | doi=10.1210/jcem.85.11.6984 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11095419  }}</ref>  
**[[Magnetic resonance imaging|MRI]] is highly sensitive to visualize the [[Hypothalamo-hypophyseal portal system|hypothalamo-hypophyseal tract]]. After the clinical and [[biochemical]] diagnosis of GHD is made.<ref name="pmid11095419">{{cite journal| author=Growth Hormone Research Society| title=Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. | journal=J Clin Endocrinol Metab | year= 2000 | volume= 85 | issue= 11 | pages= 3990-3 | pmid=11095419 | doi=10.1210/jcem.85.11.6984 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11095419  }}</ref>  
 
**On T1-weighted imaging, a clear demarcation can be made between the [[adenohypophysis]] and the [[neurohypophysis]], which appears as hyperintense.<ref name="pmid7484625">{{cite journal| author=Dietrich RB, Lis LE, Greensite FS, Pitt D| title=Normal MR appearance of the pituitary gland in the first 2 years of life. | journal=AJNR Am J Neuroradiol | year= 1995 | volume= 16 | issue= 7 | pages= 1413-9 | pmid=7484625 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7484625  }}</ref>
* On T1-weighted imaging, a clear demarcation can be made between the [[adenohypophysis]] and the [[neurohypophysis]], which appears as hyperintense.<ref name="pmid7484625">{{cite journal| author=Dietrich RB, Lis LE, Greensite FS, Pitt D| title=Normal MR appearance of the pituitary gland in the first 2 years of life. | journal=AJNR Am J Neuroradiol | year= 1995 | volume= 16 | issue= 7 | pages= 1413-9 | pmid=7484625 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7484625  }}</ref>
**This imaging is important to exclude the possibility of a [[pituitary tumor]]; it also permits diagnostic characterization by showing the presence or absence of morphological abnormalities such as [[Anterior pituitary|anterior pituitary hypoplasia]], [[Pituitary stalk|pituitary stalk agenesis]], and [[Posterior pituitary|posterior pituitary ectopia]].
 
**[[PSIS|Pituitary stalk interruption syndrome]] ([[PSIS]]) can be diagnosed using [[Magnetic resonance imaging|MRI]] aslo.<ref name="pmid10199773">{{cite journal| author=Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S et al.| title=Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. | journal=J Clin Endocrinol Metab | year= 1999 | volume= 84 | issue= 4 | pages= 1324-8 | pmid=10199773 | doi=10.1210/jcem.84.4.5614 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10199773  }}</ref>  
* This imaging is important to exclude the possibility of a [[pituitary tumor]]; it also permits diagnostic characterization by showing the presence or absence of morphological abnormalities such as [[Anterior pituitary|anterior pituitary hypoplasia]], [[Pituitary stalk|pituitary stalk agenesis]], and [[Posterior pituitary|posterior pituitary ectopia]].
 
*[[PSIS|Pituitary stalk interruption syndrome]] ([[PSIS]]) can be diagnosed using [[Magnetic resonance imaging|MRI]] aslo.<ref name="pmid10199773">{{cite journal| author=Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S et al.| title=Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. | journal=J Clin Endocrinol Metab | year= 1999 | volume= 84 | issue= 4 | pages= 1324-8 | pmid=10199773 | doi=10.1210/jcem.84.4.5614 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10199773  }}</ref>  
[[File:Ectopic-posterior-pituitary.jpg|center|300px|thumb|Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 16814]]
[[File:Ectopic-posterior-pituitary.jpg|center|300px|thumb|Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 16814]]


Line 18: Line 15:


[[File:Pituitary-stalk-interruption-syndrome-1.jpg|center|300px|thumb|Case courtesy of Dr Ayaz Hidayatov, Radiopaedia.org, rID: 52152]]
[[File:Pituitary-stalk-interruption-syndrome-1.jpg|center|300px|thumb|Case courtesy of Dr Ayaz Hidayatov, Radiopaedia.org, rID: 52152]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 17:24, 18 August 2017

Growth hormone deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Growth hormone deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Growth hormone deficiency MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Growth hormone deficiency MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Growth hormone deficiency MRI

CDC on Growth hormone deficiency MRI

Growth hormone deficiency MRI in the news

Blogs on Growth hormone deficiency MRI

Directions to Hospitals Treating Growth hormone deficiency

Risk calculators and risk factors for Growth hormone deficiency MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {MAD}}

Overview

MRI

Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 16814
Case courtesy of Dr Hani Salam, Radiopaedia.org, rID: 8518
Case courtesy of Dr Ayaz Hidayatov, Radiopaedia.org, rID: 52152

References

  1. Growth Hormone Research Society (2000). "Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society". J Clin Endocrinol Metab. 85 (11): 3990–3. doi:10.1210/jcem.85.11.6984. PMID 11095419.
  2. Dietrich RB, Lis LE, Greensite FS, Pitt D (1995). "Normal MR appearance of the pituitary gland in the first 2 years of life". AJNR Am J Neuroradiol. 16 (7): 1413–9. PMID 7484625.
  3. Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S; et al. (1999). "Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults". J Clin Endocrinol Metab. 84 (4): 1324–8. doi:10.1210/jcem.84.4.5614. PMID 10199773.